Pain Management of Vaso-Occlusive Crisis in Children and Young Adults With Sickle Cell Disease-Effect of Virtual Reality Technology
Who is this study for? Patients with sickle cell disease
What treatments are being studied? Virtual Reality Therapy
Status: Recruiting
Location: See all (2) locations...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
Objectives: * To compare total opioid consumption from the time of presentation to the time of discharge from acute care setting in Standard versus VR arms. * To assess the efficacy of virtual reality (VR) technology in reducing pain at 60 minutes after the first IV medication administered or 60 minutes after completion VR during an acute vaso-occlusive crisis in patients with sickle cell disease.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 6
Maximum Age: 25
Healthy Volunteers: f
View:
• Participant must have sickle cell disease (any genotype), documented in the St. Jude medical record.
• Participant must be seeking care for acute VOC pain at St. Jude Children's Research Hospital.
• Participant age must be ≥ 6 years and ≤ 25 years.
• English speaking
Locations
United States
Tennessee
Methodist Comprehensive Sickle Cell Center
COMPLETED
Memphis
St. Jude Children's Research Hospital
RECRUITING
Memphis
Contact Information
Primary
Michael Frett, MD
referralinfo@stjude.org
866-278-5833
Time Frame
Start Date: 2018-02-05
Estimated Completion Date: 2026-11
Participants
Target number of participants: 76
Treatments
No_intervention: Standard Care
Participants receive standard care treatment for their vaso-occlusive crisis. Participants will be randomized by age.
Active_comparator: Virtual Reality
Participants receive standard care treatment for their vaso-occlusive crisis. In addition, they will have a 15-minute Virtual Reality Therapy session. Participants will be randomized by age.
Authors
Related Therapeutic Areas
Sponsors
Leads: St. Jude Children's Research Hospital